| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.049 | 0.8 |